Business in the Burbs

EpiCept puts price on its shares

August

EpiCept Corp. of Eastview said this morning the 5.53 million shares of its stock available in an upcoming public offering will be priced at 54.3 cents apiece. The five-year warrants to buy up to 2.76 million shares will carry an exercise price of 48 cents a share, the company said.

EpiCept will take in about 2.65 million in net proceeds from the offering. The company plans to use the money for general corporate purposes and to repay a portion of a secured loan.

The company is seeking to develop drugs for cancer patients.

EpiCept last week announced it had received a regulatory approval in Europe for Ceplene, a treatment for a type of leukemia. The Committee for Medicinal Products for Human Use issued a positive opinion regarding the marketing of Ceplene.

The companyâ€™s shares were trading at 58 cents, down 8 cents, at about 10:20 a.m.

This entry was posted on Monday, August 4th, 2008 at 9:45 am by Allan Drury. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.